Bioassay-Guided Isolation of Flavonoids From Caesalpinia Bonduc (L.) Roxb. and Evaluation of Their Cytotoxicity
Bioassay-Guided Isolation of Flavonoids From Caesalpinia Bonduc (L.) Roxb. and Evaluation of Their Cytotoxicity
Bioassay-Guided Isolation of Flavonoids From Caesalpinia Bonduc (L.) Roxb. and Evaluation of Their Cytotoxicity
DOI: 10.22037/ijpr.2020.112557.13824
Received: October 2019
Accepted: April 2020
Original Article
Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran.
a
b
Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran,
Iran.
Abstract
Cancer is one of the most important causes of death all around the world. Screening plants
and their secondary metabolites as cytotoxic agents is one of the common methods for identifying
new compounds used in chemotherapy and inhibition cancer process. Caesalpinia bonduc (L.)
Roxb. from the Fabaceae family was used for improving wound, fever, tumor, hydrocele, hernia,
smallpox, toothache, inflammation, and as astringent, anthelmintic, antidiabetic, and antimalarial
agent in traditional medicine. A bioassay-guided study of this species led to the isolation of three
flavonoids. At first, the cytotoxicity of methanol extract of aerial parts (leaves and stems), seeds,
and legumes of this plant was tested against MCF-7 and PC-3 by MTT assay. The methanol
extract of legumes showed better inhibitory activities (IC50 < 500 µg/mL). As a result, this extract
was selected for fractionation. In the next step, the ethyl acetate (EtOAc) fraction was selected
for phytochemical analysis based on the inhibitory activity (IC50 = 170 ± 0.9 µg/mL). In this
way, total phenol content (625 ± 7.2 GAE/g extract) and antioxidant activity (IC50 = 6.1 ± 0.3
µg/mL) was compared by BHT (IC50 = 13.5 ± 0.7 µg/mL). Finally, three compounds including,
quercetin-3-methyl ether (1), kaempferol (2), and kaempferol-3-O-α-L-rhamnopyranosyl-
1→2)-β-D-xylopyranoside (3) were isolated from EtOAc fraction, and all isolated compounds
were tested for their cytotoxicity and compound 1 showed better inhibitory activity than other
two compounds. This study suggests that Caesalpinia bonduc could be considered for further
investigations as a natural source of biological compounds.
275
Bioassay-guided Cytotoxic Isolation of Caesalpinia bonduc
276
Pournaghi N et al. / IJPR (2021), 20 (1): 274-282
(30). First, 100 µg/mL concentration of the 3, respectively. Therefore, it was selected for
fraction solutions was prepared and oxidized further fractionation (Table 1).
with Folin-Ciocalteu solution followed In the next step, n-hexane, chloroform, ethyl
by neutralization with 7% (w/v) sodium acetate, n-butanol and water soluble fractions
carbonate. After shaking for 2 h at room were fractionated from the methanol extract
temperature, the absorption was measured at of legumes. Total phenol content, antioxidant
765 nm. Gallic acid was used as a standard and activity, and antiproliferative activity of
its solutions (50, 100, 150, 500, and 1000 µg/ fractions were measured to determine effective
mL) were prepared to draw a calibration curve. fraction for phytochemical analysis.
All standard and fractions were performed
in triplicate and total phenol content was Total phenol content of fractions
expressed as Gallic acid equivalent (GAE)/g Total phenol contents of C. bonduc
extract. fractions and methanol extract of legume
were determined and expressed as Gallic acid
DPPH radical scavenging assay equivalent (GAE)/g. Total phenol content
The Free radical-scavenging activity of varied between 175 for water fraction and 625
fractions was evaluated by the 2,2-Diphenyl-1- for ethyl acetate fraction (Table 2). As shown
picrylhydrazyl (DPPH) (31). Briefly, different in Table 2, ethyl acetate fraction has the highest
concentrations of fractions (5, 10, 20, 40, and amount of phenol content (625 GAE/g).
80 µg/mL) and 40 µg/mL solution of DPPH
in methanol were prepared. In each well of DPPH radical scavenging assay
96-well plates, 63 µL of DPPH was added to The antioxidant activity of fractions
a suitable volume of each fraction solution was determined through DPPH free radical
until the final volume became 250 µL. The scavenging activity test. The results revealed
absorbance was measured at 517 nm after 1 that ethyl acetate fraction has higher ability for
h. The test was performed in triplicate. DPPH radical scavenging activity (IC50: 6.1 µg/mL)
solution alone served as control and butylated compared to BHT (IC50: 13.5 µg/mL) (Table
hydroxytoluene (BHT) was used as standard. 2).
According to the results, a comparison of
Results and Discussion total phenol contents of fractions with their
All processes of the experiment contained DPPH radical scavenging activity shows that
phytochemical process followed by biological there is a direct relationship between the total
assays. In the first step, the methanol extracts phenol compound and antioxidant activity of
of aerial parts, seeds and legumes of C. bonduc fractions.
were prepared and tested their cytotoxicity. Antiproliferative activity of fractions
Antiproliferative activity of the legume, The methanol extract of legumes and all
seed, and aerial part extracts fractions were tested for their cytotoxicity
MTT assay was applied to determine which against three human cancer cell lines (MCF-7,
extract had better antiproliferative activity and HepG-2, and PC-3) using the MTT assay. The
fewer IC50. The results showed that the MeOH IC50 values were measured (Table 3). Ethyl
extract of legumes had the least IC50 value of acetate fraction showed better activity against
483 and 337 µg/mL against MCF-7 and PC- all of the tested cell lines. It should be noted
Table 1.
Table 1. Antiproliferative Antiproliferative
activity activityextracts
of the methanol of the methanol extracts cell
on the cancer on the cancer
lines cell ±
(Mean lines
SD,(Mean ± SD, n = 3).
n = 3).
IC50 (µg/mL)
Extract MCF-7 PC-3
48 (h) 72 (h) 48 (h) 72 (h)
Legume 546 ± 0.5 483 ± 1.2 456 ± 1.9 337 ± 1.1
Seed >1000 >1000 800 ± 2.2 730 ± 4.2
Aerial part >1000 850 ± 6.1 780 ± 5.3 510 ± 3.1
277
Bioassay-guided Cytotoxic Isolation of Caesalpinia bonduc
that we used 72 h of incubation at 37 °C in this 5-OH), 7.54 (1H, d, J = 2.2 Hz, H-2′), 7.45
test because it had better response in previous (1H, dd, J = 8.35, 2.2 Hz, H-6′), 6.91 (1H, d,
test. J = 8.35 Hz, H-5′), 6.39 (1H, d, J = 2.00 Hz,
According to the results listed above (total H-8), 6.18 (1H, d, J = 2.00 Hz, H-6), 3.78 (3H,
phenol content, DPPH radical scavenging assay s,3-OCH3);13C-NMR (125 MHz, DMSO-d6);
and antiproliferative activity of fractions), the δ 178.21 (C-4), 165.21 (C-7), 161.65 (C-5),
ethyl acetate fraction was selected for more 156.80 (C-9), 155.93 (C-2), 149.28 (C-4′),
fractionations and purification. 145.73 (C-3′), 138.11 (C-3), 121.13 (C-1′),
In the final step, from the bioactive guided 120.99 (C-5′), 116.18 (C-2′), 115.74 (C-6′),
fractionation of ethyl acetate fraction of C. 104.35 (C-10), 99.14 (C-6), 94.11 (C-8), 60.09
bonduc legume, three flavonoids (compounds (OCH3); EI-MS m/z: [M+H]+ 317 (32,27).
1 to 3) were obtained. Fractionation Compound 2: Kaempferol (C15H10O6);
and purification of ethyl acetate fraction pale yellow powder; 1H-NMR (500 MHz,
were performed by the Sephadex LH- DMSO-d6); δ 12.73 (1H, 5-OH), 8.10 (2H,
20 column chromatography and silica gel d, J = 9.7 Hz, H-2′, 6′), 6.92 (2H, d, J = 9.7
plate chromatography. The structures of the Hz, H-3′, 5′), 6.79 (1H, br s, H-8), 6.25 (1H,
isolated compounds were characterized as br s, H-6); 13C-NMR (125 MHz, DMSO-d6);
Quercetin-3-methyl ether (1), Kaempferol δ 180.36 (C-4), 164.92 (C-7), 162.00 (C-5),
(2), Kaempferol-3-O-α-L-rhamnopyranosyl- 161.63 (C-4′). 157.90 (C-9), 149.50 (C-2),
1→2)-β-D-xylopyranoside (3) using 135.21 (C-3), 130.12 (C-2′, 6′), 121.45 (C-1′),
1
H-NMR, C-NMR, and MS evaluations, as
13 116.31 (C-5′, 3′), 103.52 (C-10), 99.70 (C-6),
well as comparison with those reported in the 94.50 (C-8) (33).
literature (32, 33 and 27). Figure 2 illustrates Compound 3: Kaempferol-3-O-α-L-
the chemical structures of compounds 1-3. rhamnopyranosyl-1→2)-β-D-xylopyranoside
(C26H28O14); pale yellow crystalline solid;
Spectroscopic data of the isolated 1
H-NMR (500 MHz, DMSO-d6); 7.98 (2H,
compounds d, J = 8.85 Hz, H-2′,6′), 6.89 (2H, d, J =8.35
Compound 1: Quercetin-3-methyl ether Hz, H-3′,5′), 6.17 (1H, br s, H-8), 5.97 (1H,
(C16H12O7); pale yellow crystalline solid; br s, H-6), 5.52 (1H, d, J = 7.35 Hz, H-1′′),
1
H-NMR (500 MHz, DMSO-d6); δ 12.70 (1H, 5.09 (1H, s, H-1′′′); 13C-NMR (125 MHz,
Table 2. Results of the total phenol content and DPPH IC50 (Mean ± SD, n = 3).
Table 2. Results of the total phenol content and DPPH IC50 (Mean ± SD, n = 3).
a
Values presented mean ± SD of triplicate experiments.
a
Values presented mean ± SD of triplicate experiments.
278
Pournaghi N et al. / IJPR (2021), 20 (1): 274-282
DMSO-d6); δ 176.84 (C-4), 167.05 (C-7), antiproliferative activity with IC50 values of
161.40 (C-5), 160.83 (C-4′). 157.08 (C-9), 45 µg/mL against PC-3, but it showed low
155.27 (C-2), 132.59 (C-3), 130.77 (C-2′,6′), antiproliferative activity with IC50 values
121.04 (C-1′), 115.74 (C-5′,3′), 107.01 (C-10), of 78 and 99 µg/mL against MCF-7 and
102.30 (C-1′′′), 101.10 (C-1′′), 99.69 (C-6), HepG-2, respectively. Previous investigation
88.70 (C-8), 77.60 (C-2′′), 77.35 (C-3′′), 72.31 has proven the cytotoxicity of compound 1
(C-4′′), 70.99 (C-2′′′), 70.18 (C-5′′′), 68.83 (C- against Hela cell line and mouse epidermal
5′′), 17.89 (C-6′′′); EI-MS m/z: [M+H]+565 JB6 P1 cells (27, 34). Compounds 2 and 3
(32, 27). did not show any significant antiproliferative
activity, and both had IC50 values greater than
Antiproliferative activity of isolated 100 µg/mL. The lack of cytotoxic activity of
compounds compound 3 might be due to the additional
The isolated compounds were tested for sugar component attached at position 3 of the
antiproliferative activity against MCF-7 C-ring so that increasing their polarity and
(human breast cancer), HepG-2 (human liver limiting their cellular permeability and also
cancer) and PC-3 (human prostate cancer). increased molecular weight of compound
The results of the in-vitro antiproliferative 3 might limit its cellular permeability (35).
activity of the compounds isolated from C. Due to the structure of the compounds and its
bonduc are summarized in Table 4. relationship with antiproliferative activity, the
The results show that compound 1 presence of a hydroxyl group at 3’ of the B-ring
(Quercetin 3- methyl ether) has moderate and methylation of the 3 hydroxyl group at
R2
3'
OH
2'
4'
8 1
HO 7 9 O 2 5'
1'
6'
6 3
10 R1
5 4
OH O
Table 4. In-vitro cytotoxic activities of isolatedTable 4. In-vitro cytotoxic activities of isolated compounds.
compounds.
279
Bioassay-guided Cytotoxic Isolation of Caesalpinia bonduc
the C-ring are the factor for increasing this from the Medicinal Plants Research Center,
property. Institute of Medicinal Plants, ACECR. This
It is necessary to mention that article is a result of PhD dissertation of Narges
different flavonoid compounds were Pournaghi. The authors wish to thank Mrs
separated from this plant, for example Mona Ghiasi-Yekta, Dr. Saeedeh Momtaz and
caesalpinianone, 6-O- methylcaesalpinianone, Dr. Saeed Tavakoli for their assistance.
7-hydroxy-4’-methoxyl-3,11-
dehydrohomoisoflavanone, 4,4’-dihydroxy- References
2’-methoxy-chalcone, 7,4’-dihydroxy- (1) Ma X and Yu H. Global burden of cancer. Yale J.
3,11-dehydrohomoisoflavanone, luteolin Biol. Med. (2006) 79: 85-94.
and kaempferol-3-O-β-D-xylopyranoside. (2) Farrakh A. The global burden of cancer [serial online].
Also the cytotoxicity of some of these (2007) [cited 2009 Jun 2]. Available from: URL:
compounds was investigated. 7,4’-Dihydroxy- http://www.cancer.gov/newscenter/benchmarks-
3,11-dehydrohomoisoflavanone had vol7-issue2.
antiproliferative activity against Hela and (3) Pedram M, Mohammadi M, Naziri GH and Aeinparast
BGC 823 cells lines and also luteolin had N. Effectiveness of cognitive-behavioral group
antiproliferative activity against Hela cells therapy on the treatment of anxiety and depression
lines (27). disorders and on raising hope in women with breast
Various mechanisms have been proposed for cancer. J. Wom. Soc. (2011) 1: 61-75.
flavonoids cytotoxicity, including inhibition of (4) Mehrinejad A, Khosrovani Shariati SH and Hossein
DNA replication, activating path of apoptosis, Abad Shapouri H. Stress in women with breast
cancer compared to the healthy ones. Daneshvar
inhibition of oxidative processes, and
Raftar (2010) 17: 49-56.
decreasing level of redox-active proteins (36-
(5) Sheldon CA, Williams RD and Farely EE. Incidental
39). Other reports showed that polyhydroxylic
carcinoma of the prostate cancer, a review of the
flavonoids and quercetin inhibit the growth of literature and critical reappraisal of classification. J.
cancer cells and reduce DNA production and Urol. (1980) 124: 626.
prevent cell crossing from cell cycle G1 step (6) Mohammadi M, Kashfee F, Nikoofar A and Hoseini
to S step (40). In most of these investigations, F. Risk factors of breast cancer. Iran J. Nurs. (2000)
there is a correlation between phenol 13: 23-30.
compounds and the antioxidant capacity of (7) Cragg GM and Newman DJ. Plants as a source of
the extracts and their effects on cancer cells. In anti-cancer agent. J. Ethnopharmacol. (2005) 100:
this study, the biochemical pathways and the 72-9.
mechanism of action of EtOAc fraction and (8) Cutler SJ and Culter HG. Biologically active natural
compound 1 in inhibition of cancer cells were products Pharmaceuticals. CRC Press, Virgivia
not investigated. However, it was found that (2000) 1: 25-7.
the extract has antioxidant compounds and (9) Khalighi-Sigaroodi F, Hadjiakhoondi A, Ahvazi M,
there is a correlation between flavonoids and Taghizadeh M, Yazdani D and Khalighi-Sigaroodi
Sh. Cytotoxicity screening of twenty-three species
cancer growth inhibition.
of Iranian Leguminosae. 3rd Congress of Medicinal
Conclusion Plants. Shahed University, 24 and 25 October (2007)
Tehran, Iran.
The results of this study show that ethyl (10) Khalighi-Sigaroodi F, Ahvazi M, Hadjiakhoondi A,
acetate fraction of C. bonduc legume has Taghizadeh M, Yazdani D, Khalighi-Sigaroodi S and
antioxidant properties and inhibition effects Bidel S. Cytotoxicity and antioxidant activity of 23
on cancer cell lines. These effects are related plant species of Leguminosae family. Iran. J. Pharm.
to the presence of secondary metabolites, Res. (2012) 11: 295-302.
especially flavonoids. Further studies are (11) Khalighi-Sigaroodi F, Jeddi-Tehrani M, Ahvazi
M, Shahnazi S, Bayat AA, Mohajer N and Zarei S.
needed to determine all components with anti-
Cytotoxicity evaluation of two plant species from
cancer effects in C. bonduc.
Leguminosae family on human cancer cell lines. 2nd
Acknowledgments National Congress of Medicinal Plants. National
Network of Research and Technology in Medicinal
This work was supported by grants Plants, 15 and 16 May (2013) Tehran, Iran.
280
Pournaghi N et al. / IJPR (2021), 20 (1): 274-282
(12) Pournaghi N, Khalighi-Sigaroodi F, Safari E and (Fabaceae). Phytochem. Lett. (2009) 2: 106-9.
Hajiaghaee R. Investigation of cytotoxicity effect (26) Peter SR, Tinto WF, McLean S, Reynolds WF
of Caesalpinia bonduc on prostate cancer cell line. and Yu M. Bonducellpins A-D, New Cassane
7th National Congress of Medicinal Plants. National Furanoditerpenes of Caesalpinia bonduc. J. Nat.
Network of Research and Technology in Medicinal Prod. (1997) 60: 1219-21.
Plants, 12 and 14 May (2018) Shiraz, Iran. (27) Ogunlana OO, He WJ, Fan JT, Zeng GZ, Ji CJ,
(13) Pournaghi N, Khalighi-Sigaroodi F, Safari E and Zeng YQ, Olagunju JA, Akindahunsi AA and Tan
Hajiaghaee R. A review of the genus Caesalpinia L.: NH. Cytotoxic flavonoids from the young twigs and
emphasis on the cassane and norcassane compounds leaves of Caesalpinia bonduc (Linn) Roxb. Pak. J.
and cytotoxicity effects. J. Med. Plants (2020) 19: Pharm. Sci. (2015) 28: 2191-8.
1-20. (28) Khalighi-Sigaroodi F, Hadjiakhoondi A, Ahvazi
(14) Mozaffarian V. A dictionary of Iranian plant names. M, Taghizadeh M, Yazdani D, Khalighi-Sigaroodi
4thed. Farhang Moaser, Tehran (2006) 89. Sh. Cytotoxicity evaluation of two species from
(15) The Plant List (2013). Version 1.1. [accessed 2020 Caesalpinia genus. J. Med. Plants (2008) 7: 60-70.
February 2]. Available from: URL: http://www. (29) Tavakoli S, Delnavazi MR, Hadjiaghaee R, Jafari
theplantlist.org. Nodooshan S, Khalighi-Sigaroodi F, Akhbari M,
(16) Ghahremaninejad F. Flora of Iran. Research Hadjiakhoondi A and Yassa N. Bioactive coumarins
Institute of Forests and Rangelands, Tehran (2004) from the roots and fruits of Ferulago trifida Boiss.,
45: 3-7. an endemic species to Iran. Nat. Prod. Res. (2017)
(17) Singh V and Raghav PK. Review on pharmacological 32: 1-5.
properties of Caesalpinia bonduc L. Int. J. Med. (30) Bayrami A, Hadjiaghaee R, Khalighi-Sigaroodi
Arom. Plants (2012) 2: 514-30. F, Rahimi R, Farzaei MH, Hodjat M, Baeeri M,
(18) Asif Saeed M and Sabir AW. Antibacterial activity Mahban R, Navaei-Nigjeh M and Abdollahi M.
of Caesalpinia bonducella seeds. Fitoterapia (2001) Bio-guided fractionation and isolation of active
72: 807-9. component from Tragopogon graminifolius based
(19) Parameshwar S, Srinivasan KK and Mallikarjuna on its wound healing property. J. Ethnopharmacol.
Rao C. Oral antidiabetic activities of different (2018) 226: 48-55.
extracts of Caesalpinia bonducella seed kernels. (31) Sharma OP and Bhat TK. DPPH antioxidant assay
Pharm. Biol. (2002) 40: 590-5. revisited. Food Chem. (2009) 113: 1202-5.
(20) Gupta M, Mazumder UK, Sambath KR, Thangavel (32) Ogunlana OO, Kim H, Wataya Y, Olagunju JO,
S and Vamsi MLM. Antitumor activity and Akindahunsi AA and Tan NH. Antiplasmodial
antioxidant status of Caesalpinia bonducella against flavonoid from young twigs and leaves of
ehrlich ascites carcinoma in Swiss albino mice. J. Caesalpinia bonduc (Linn) Roxb. J. Chem. Pharm.
Pharmacol. Sci. (2004) 94: 177-84. Res. (2015) 7: 931-7.
(21) Muruganantham N, Basavaraj KH, Dhanabal (33) Sathyadevi M and Subramanian S. Extraction,
SP, Praveen TK, Shamasundar NM and Rao isolation and characterization of bioactive flavonoids
KS. Screening of Caesalpinia bonduc leaves for from the fruits of Physalis peruviana Linn extract.
antipsoriatic activity. J. Ethnopharmacol. (2011) Asian J. Pharm. Clin. Res. (2015) 8: 152-7.
133: 897-901. (34) Li J, Mottamal M, Li H, Liu K, Zhu F, Cho YY,
(22) Datte JY, Traore A, Offoumou AM and Ziegler Sosa CP, Zhou K, Bowden GT, Bode AM and Dong
A. Effects of leaf extract of Caesalpinia bonduc Z. Quercetin-3-methyl ether suppresses proliferation
(Caesalpiniaceae) on the contractile activity of mouse epidermal JB6 P1 cells by targeting ERKs.
of uterine smooth muscle of pregnant rats. J. Carcinogenesis (2012) 33: 459-65.
Ethnopharmacol. (1998) 60: 149-55. (35) Spencer JP. Metabolism of tea flavonoids in the
(23) Wu L, Luo J, Zhang Y, Wang X, Yang L and Kong gastrointestinal tract. J. Nutr. (2003) 133: 3255-61.
L. Cassane-type diterpenoids from the seed kernels (36) Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC,
of Caesalpinia bonduc. Fitoterapia (2014) 93: 201- Huang YT and Lee MT. The antitumor activities of
8. flavonoids. In Vivo (2005) 19: 895-909.
(24) Yadav PP, Maurya R, Sarkar J, Arora A, Kanojiya (37) Ramos S. Effects of dietary flavonoids on apoptotic
S, Sinha S, Srivastava MN and Raghubir R. Cassane pathways related to cancer chemoprevention. J. Nutr.
diterpenes from Caesalpinia bonduc. Phytochemistry Biochem. (2007) 18: 427-42.
(2009) 70: 256-61. (38) Kumar S and Pandey AK. Chemistry and Biological
(25) Ata A, Gale EM and Samarasekera R. Bioactive Activities of Flavonoids: An Overview. Sci. World J.
chemical constituents of Caesalpinia bonduc (2013) 2013: 1-16.
281
Bioassay-guided Cytotoxic Isolation of Caesalpinia bonduc
(39) Omarniyaz Z, Yu Y, Yang T, Shan L, Miao W, Reyimu epigenetic alteration in Eca9706 cells modulated by
R, Upur H and Aikemu A. Anti-tumor effects of nanoliposomal quercetin combined with butyrate
abnormal Savda Munziq on the transplanted cervical mediated via epigenetic-NF-κB signaling. Asian
cancer (U27) mouse model. BMC Complement. Pac. J. Cancer Prev. (2014) 15: 4539–43.
Altern Med. (2016) 16: 477.
(40) Zheng NG, Wang JL, Yang SL and Wu JL. Aberrant This article is available online at http://www.ijpr.ir
282